DRMCX
Price
$6.06
Change
-$0.22 (-3.50%)
Updated
Feb 21 closing price
Net Assets
372.04M
PMBPX
Price
$44.27
Change
-$0.76 (-1.69%)
Updated
Feb 21 closing price
Net Assets
30.08B
Ad is loading...

DRMCX vs PMBPX

Header iconDRMCX vs PMBPX Comparison
Open Charts DRMCX vs PMBPXBanner chart's image
Virtus Silvant Mid-Cap Growth Inst
Price$6.06
Change-$0.22 (-3.50%)
VolumeN/A
Net Assets372.04M
Principal MidCap R5
Price$44.27
Change-$0.76 (-1.69%)
VolumeN/A
Net Assets30.08B
DRMCX vs PMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DRMCX vs. PMBPX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRMCX is a StrongBuy and PMBPX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 30.1B vs. DRMCX (372M). DRMCX (0.00) and PMBPX (0.00) have matching dividends . DRMCX was incepted earlier than PMBPX: DRMCX (45 years) vs PMBPX (24 years). DRMCX is a more actively managed with annual turnover of: 34.00 vs. PMBPX (10.10). PMBPX has a lower initial minimum investment than DRMCX: PMBPX (0) vs DRMCX (1000000). DRMCX annual gain was more profitable for investors over the last year : 26.88 vs. PMBPX (17.07). PMBPX return over 5 years is better than : 38.64 vs. DRMCX (31.29).
DRMCXPMBPXDRMCX / PMBPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence45 years24 years-
Gain YTD9.1844.533203%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets372M30.1B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year26.8817.07157%
Returns for 3 years32.3729.51110%
Returns for 5 years31.2938.6481%
Returns for 10 years59.7097.5161%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY17.330.44
+2.61%
Bally's Corporation
BIO285.631.90
+0.67%
Bio-Rad Laboratories IncClass A
GPUS3.150.02
+0.64%
Hyperscale Data Inc
PTGX38.49-0.04
-0.10%
Protagonist Therapeutics
MIST2.06-0.07
-3.29%
Milestone Pharmaceuticals